These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4181094)

  • 1. [Clinical application of PPC for prostatic hypertrophy and female cystopathy].
    Nishimura Y; Ikeda T
    Hinyokika Kiyo; 1969 Feb; 15(2):127-34. PubMed ID: 4181094
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double blind test of PPC for prostatic hyperplasia].
    Shimaya M; Sugiura H
    Hinyokika Kiyo; 1970 May; 16(5):231-6. PubMed ID: 4194682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of Prosta-caps].
    Weiser
    Dtsch Med J; 1972 Feb; 23(2):155-6. PubMed ID: 4111749
    [No Abstract]   [Full Text] [Related]  

  • 4. [A gastroprotective nitrofuran in urological practice].
    Laudi M; Ferrando U; Fontana G; Sesia G
    Minerva Urol; 1975; 27(2):83-90. PubMed ID: 49842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of amino acids as a combination in the treatment of prostatic hypertrophy].
    Menéndez Fernández H; Castillo Vergara P; Hilario García Marcos J; Romero Gil JR
    Arch Esp Urol; 1988 Sep; 41(7):495-9. PubMed ID: 2468315
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical effect of PPC for the palliative treatment of benign prostatic hypertrophy].
    Ishigami J; Kuroda K
    Hinyokika Kiyo; 1969 Jan; 15(1):68-75. PubMed ID: 4180035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of "PPC" to prostatic hypertrophy and others].
    Sugiura H; Shimaya M
    Hinyokika Kiyo; 1969 Jun; 15(6):450-3. PubMed ID: 4185864
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of streptokinase instead of surgical interference for the treatment of urinary clot retention.
    Hanna A
    Urol Surv; 1979 Aug; 29(4):111-2. PubMed ID: 90421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?
    McVary KT
    Eur Urol; 2006 Dec; 50(6):1153-6. PubMed ID: 17045387
    [No Abstract]   [Full Text] [Related]  

  • 10. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 11. [Some personal comments on the care given to patients with benign prostatic hypertrophy in the primary care environment].
    Pellicé i Vilalta C
    Arch Esp Urol; 1998; 51(1):1-4. PubMed ID: 9557335
    [No Abstract]   [Full Text] [Related]  

  • 12. [The irritable bladder as a test object for spasmolytics. Experimental and clinical testing of benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate].
    von Rütte B
    Arzneimittelforschung; 1966 Aug; 16(8):929-35. PubMed ID: 4172009
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences in the treatment of prostatic hypertrophy with high doses of progesterone administered rectally].
    Marini A; Cavalca GG
    Minerva Urol; 1974; 26(3):140-5. PubMed ID: 4138638
    [No Abstract]   [Full Text] [Related]  

  • 14. Deep vein thrombosis associated with distension of the urinary bladder due to benign prostatic hypertrophy--a case report.
    Meinardi JR; Kremer J; van der Meer J
    Neth J Med; 2004 Apr; 62(4):137-8. PubMed ID: 15255085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Androgen deprivation in benign prostatic hypertrophy].
    Tenaglia R; Nicolai M; Di Federico G; Iantorno R; Zezza A; Lombardi G
    J Urol (Paris); 1993; 99(6):296-8. PubMed ID: 7516371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experiences with phyto-therapy of benign prostatic hypertrophy].
    Bauer KM
    Med Welt; 1980 Aug; 31(34):1211-4. PubMed ID: 6159518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Urological diseases and salivary gland hormone. (1). Prostatic hypertrophy. (2). Functional failure of the bladder].
    Furusawa T; Azuma T; Mishina T; Murakami T
    Horumon To Rinsho; 1966 Nov; 14(11):915-7. PubMed ID: 4167004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of prostatic hypertrophy with depostat].
    Nuri M; Hochberg K
    Munch Med Wochenschr; 1970 May; 112(22):1057-60. PubMed ID: 4192989
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phenotypic changes in human bladder smooth muscle cell].
    Matsumoto S; Hanai T; Kurita T; Akiyama T
    Hinyokika Kiyo; 2003 Dec; 49(12):715-9. PubMed ID: 14978953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.